PROJECTS
ABOUT-MDRO
Systematic literature review of the burden and outcomes of infections due to multidrug-resistant organisms in Europe
AMMURAVID
Factorial, multicentric, randomized clinical trial of remdesivir and immunotherapy in combination with dexamethasone for moderate COVID-19 (the AMMURAVID trial)
AMR in RSA
Punctual prevalence surveillance of healthcare-associated infections, enteric colonization by multi-drug resistant bacteria and consumption of antibiotics in long-term care facilities (LTCFs) in the Veneto region.
ARCH-NET
Bridging the gap between humAn and animal suRveillance data, antibiotic poliCy, and stewardsHip
BIOSTEPS
Antibiotic stewardship program (ASP) in pancreatic surgery: a multicenter time series analysis
COACH
Linking antimicrobial resistance surveillance to antibiotic policy in healthcare settings: the COMBACTE-Magnet EPI-Net COACH project
COHERENCE
Combination therapy to treat sepsis due to carbapenem-resistant bacteria in adult and paediatric population: evidence and common practice
COMBACTE-MAGNET ENSURE
ENforcing SUrveillance of Antimicrobial Resistance and antibiotic usE to drive Stewardship
COMBACTE-MAGNET Epi-Net AMR Travel Tool
Combacte-Magnet EPI-Net Antimicrobial Resistance Travel Tool
CONNECT
Increasing communication, awareness and data sharing in a global approach against resistance
Chemsex MSM
Chemsex use among MSM in Verona: prevalence study among HIV/STIs clinic attendees at high risk for HIV/STIs.
ENACT - REACT COVID (risk assessment)
Registry of COVID-19 Patients at AOUI Verona (ENACT – REACT COVID)
ENACT-SOS COVID
Seroprevalence assessment of SARS-CoV2 infections amongst healthcare professionals working in the 4 main hospitals of the Verona province and in their cohabitants.
EU-RESPONSE
European DisCoVeRy for Solidarity: An Adaptive Pandemic and Emerging Infection Platform Trial – EUropean RESearch and Preparedness netwOrk for pandemics and emerging iNfectious diseaSEs
LTCF-VENETO
Punctual prevalence surveillance of healthcare-associated infections, enteric colonization by multi-drug resistant bacteria and consumption of antibiotics in long-term care facilities (LTCFs) in the Veneto region.
MANTICO
Adaptive group sequential randomized control trial (Phase III) to assess the efficacy of monclonal antibodies for the treatment of light to moderate COVID-19 disease.
ORCHESTRA
Connecting European Cohorts to Increase Common and Effective Response to SARS-CoV-2 Pandemic
PRIMAVERA
PrIMAVeRa - Predicting the Impact of Monoclonal Antibodies & Vaccines on Antimicrobial Resistance.
REVERSE
Prevention and management tools for reducing antibiotic resistance in high prevalence settings.
SOLIDARITY-Italy
An international randomised trial of additional treatments for COVID-19 in hospitalised patients who are all receiving the local standard of care
SRH COVID
Health systems analysis and evaluations of the barriers to availability, utilisation and readiness of selected sexual and reproductive health services in COVID-19 affected areas.
VALUE-DX
The value of diagnostics to combat antimicrobial resistance by optimising antibiotic use